ALX Oncology Holdings Inc.

NASDAQ:ALXO

Biotechnology

Healthcare
$0.97 -2.12%

-$0.03 today

Market cap
$134.14M
Beta
0.45
P/E (TTM)
-0.9
EPS (TTM)
-$1.64
52W Low $0.40High $2.66

Volume 0.56M

Average 1.07M

Balance Sheet

Inspect the capital base behind the business.

Assets

$59.05M

FY 2025 · Annual

-60.0% YoY

Liabilities

$33.06M

FY 2025 · Annual

-3.2% YoY

Equity

$25.98M

FY 2025 · Annual

-77.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents363.67M48.82M22.41M17.57M16.37M
Short-term Investments0217.39M160.33M110.19M28.42M
Net Receivables000892K298K
Inventory00000
Other Current Assets04.76M5.92M5.7M5.64M
Total Current Assets367.02M270.97M188.66M134.35M50.73M
Property, Plant & Equipment (Net)3.47M9.81M10.84M9.63M1.2M
Goodwill00000
Intangible Assets00000
Long-term Investments016.7M35.41M3.52M3.49M
Tax Assets00000
Other Non-current Assets9.69M9.01M7.64M267K3.63M
Total Non-current Assets13.16M35.52M53.89M13.42M8.32M
Total Assets380.18M306.49M242.55M147.78M59.05M
Account Payables3.76M8.07M8.59M4.5M4.91M
Short-term Debt000435K5.22M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities3.53M4.72M6.7M5.97M14.42M
Total Current Liabilities15.3M28.33M36M18.5M24.55M
Long-term Debt09.39M9.64M9.47M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.84M5.31M1.22M1.03M8.51M
Total Non-current Liabilities1.84M14.7M16.84M15.66M8.51M
Total Liabilities17.13M43.03M52.84M34.16M33.07M
Common Stock41K41K50K53K54K
Retained Earnings(201.99M)(325.47M)(486.27M)(621.12M)(722.82M)
Accumulated OCI(0)(845K)256K275K28K
Other Stockholders Equity00000
Minority Interest00000
Total Equity363.05M263.46M189.71M113.62M25.98M
Total Debt742K10.43M17.2M16.98M5.22M
Net Debt(362.93M)(38.39M)(5.21M)(589K)(11.16M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$32.3M
Short-term Investments$108.0M
Other Current$5.2M
Total Current Assets$145.6M
PP&E (Net)$1.1M
Long-term Investments$28.8M
Other Non-current$2.9M
Total Non-current Assets$32.8M
Total Assets$178.3M

Analysis

Selected assets total $178.3M for Latest. The largest visible component is Short-term Investments at $108.0M, about 60.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingOct 16, 2026
8-KCurrent reportOct 15, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much cash does ALXO have?

ALX Oncology Holdings Inc. (ALXO) reported $16.37M in cash and equivalents in fiscal 2025.

How much debt does ALXO carry?

ALX Oncology Holdings Inc. (ALXO) reported $5.22M of total debt, with net debt of -$11.16M.